Oncogene Cancer Research shared a post on LinkedIn:
“Did you know that some cancer treatments cause cardiotoxicity – the risk of heart or circulatory problems?
These cancer treatments range from chemotherapy, radiotherapy, immunotherapy and targeted therapies (including those for ALK, EGFR and HER2 cancers).
Integrating cardio-oncology into multidisciplinary care teams is key. We patients should never have to choose between treating our cancers and protecting our hearts.
Visit the website for more info including a patient guide with links to clinical practice guidelines.
February is the month of love and heart awareness. Stay tuned for further info this month.”
More posts featuring Oncogene Cancer Research.
